INVO Bioscience, Inc. offers novel solutions in assisted reproductive technologies ART while expanding geographic and affordable access to the global reproductive health care community. Our primary focus is the manufacture and sale of the INVOcell device and the INVO technology to assist infertile couples in having a baby. We designed our INVOcell device and our INVO procedure to provide an alternative infertility treatment for the patient and the clinician. The INVO procedure is less expensive and simpler to perform than most comparable infertility treatments currently. The simplicity of the INVO procedure relates to the ability to potentially perform the INVO procedure in a physician s practice rather than in a specialized facility at a much lower cost overall than current infertility treatments. lt br / gt lt br / gt We believe that the INVO procedure will make infertility treatment more readily available throughout the world. The INVO procedure is significantly less costly than conventional in vitro fertilization IVF . The INVOcell device and INVO procedure facilitates conception and embryo development inside the woman s body, rather than in a dish in a laboratory, which is an attractive feature for most couples.
Quote | INVO BioScience, Inc. (OTCMKTS:IVOB)
Last: | $ |
---|---|
Change Percent: | -1.96% |
Open: | $0.248 |
Close: | $0.2549 |
High: | $0.2549 |
Low: | $0.2351 |
Volume: | 45,161 |
Last Trade Date Time: | 02/12/2020 04:09:14 pm |
News | INVO BioScience, Inc. (OTCMKTS:IVOB)
SARASOTA, Fla. , May 15, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today anno...
SARASOTA, Fla. , April 2, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO) , a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, announced today the appointment of Christopher A. Myer as Vice President Business Development ...
Message Board Posts | INVO BioScience, Inc. (OTCMKTS:IVOB)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
INVO BioScience, Inc. Company Name:
IVOB Stock Symbol:
OTCMKTS Market:
INVO BioScience, Inc. Website:
SARASOTA, Fla. , May 15, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today anno...
SARASOTA, Fla. , April 2, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO) , a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, announced today the appointment of Christopher A. Myer as Vice President Business Development ...
SARASOTA, Fla. , March 11, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, today announced that Yve Lyppens has been appointed Director Business Development Asia Pacific....